查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426215

單核細胞增多性李斯特感染疾病治療全球市場報告 2024 年

Listeria Monocytogenes Infections Treatment Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

單核細胞增多性李斯特菌感染疾病治療的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 5.1% 的複合年成長率 (CAGR) 成長至 58.6 億美元。預測期內單核細胞增多性李斯特菌感染疾病控制的預期成長歸因於食品供應鏈的全球化、抗菌治療的持續研發努力、用餐模式的改變、醫療保健、感染疾病方面國際合作的加強，這與以下幾個因素有關：包括增加興趣

由於食源性疾病的盛行率不斷增加，單核細胞增多性李斯特菌感染疾病治療市場可望成長。這些因攝取受污染的食品或飲料而引起的疾病包括與單核細胞增多性李斯特菌感染有關的問題。治療這些感染疾病可以降低疾病的風險和嚴重程度。特別是，2022年12月，歐洲食品安全局報告稱，食品相關事故增加了29.8%，與前一年同期比較， 2021年記錄了約4,005起事件。這項擴張凸顯出食物中毒發生率的上昇在推動單核細胞增多性李斯特菌感染疾病治療市場方面發揮關鍵作用。

政府主導的醫學研究和開發措施旨在加強單核細胞增多性李斯特菌感染疾病治療市場。這些努力包括政府機構為解決醫療保健問題而採取的有針對性的行動、政策或資助計劃。特別是，英國政府承諾在 2022 年斥資 2.6 億英鎊（2.7065 億美元）用於醫學研究和製造，就是這項承諾的明證。這筆巨額資金旨在支持 NHS主導的健康研究、診斷和治療的隱私保護平台以及生命科學製造的擴張。這種政府支持對單核細胞增多性李斯特菌感染疾病治療市場的成長軌跡有重大影響。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球單核細胞增多性李斯特菌感染疾病治療市場的促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023年全球單核球增多性李斯特菌感染疾病治療市場規模表現與成長
  • 2023-2028年、2033年全球單核球增多性李斯特菌感染疾病治療市場規模及成長預測

第6章市場區隔

  • 全球單核球增多性李斯特菌感染疾病治療市場，依藥物類別、表現及預測細分，2018-2023、2023-2028、2033
  • Ampicillin
  • 慶大霉素
  • 萬古黴素
  • 其他
  • 全球單核細胞增多性李斯特菌感染疾病治療市場，依感染疾病類型、實際及預測細分，2018-2023、2023-2028、2033
  • 胃腸炎
  • 心內膜炎
  • 腦膜炎
  • 菌血症
  • 腦膿腫
  • 全球單核球增多性李斯特菌感染疾病治療市場，依管理方法細分，實際與預測，2018-2023、2023-2028、2033
  • 口服
  • 注射
  • 其他
  • 全球單核細胞增多性李斯特菌感染疾病治療市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 醫院
  • 居家醫療
  • 專科診所
  • 其他

第 7 章 區域與國家分析

  • 全球單核球增多性李斯特菌感染疾病治療市場，依地區、實際及預測，2018-2023、2023-2028、2033
  • 全球單核球增多性李斯特菌感染疾病治療市場，依國家、表現及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 單核球增多性李斯特菌感染疾病治療市場競爭形勢
  • 單核細胞增生李斯特感染疾病治療市場公司概況
    • Emergent Bio Solutions Inc.
    • Pfizer Inc.
    • LimmaTech Biologics AG
    • GlaxoSmithKline plc
    • ZydusCadila Health Care Ltd

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來前景與潛力分析

第35章附錄

簡介目錄
Product Code: r13237

Treatment for Listeria monocytogenes infection involves medical interventions and therapeutic measures aimed at addressing and managing infections caused by this bacterium. Listeria monocytogenes is a pathogenic bacterium responsible for causing a serious illness called listeriosis in humans. This infection usually arises when individuals ingest contaminated food or beverages containing Listeria monocytogenes.

The main classes of drugs used for listeria monocytogenes infections treatment are Ampicillin, Gentamicin, Vancomycin, and others. Several types of infections include gastroenteritis, endocarditis, meningitis, bacteremia, and brain abscess. The drugs can be administered through various modes, such as oral, injectable, and other modes and are used by several end users, including hospitals, home care, specialty clinics, and others.

The listeria monocytogenes infections treatment market research report is one of a series of new reports from The Business Research Company that provides listeria monocytogenes infections treatment market statistics, including listeria monocytogenes infections treatment industry global market size, regional shares, competitors with a listeria monocytogenes infections treatment market share, detailed listeria monocytogenes infections treatment market segments, market trends and opportunities, and any further data you may need to thrive in the listeria monocytogenes infections treatment industry. This listeria monocytogenes infections treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The listeria monocytogenes infections treatment market size has grown strongly in recent years. It will grow from $4.52 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. Historical growth in addressing Listeria monocytogenes infections was largely driven by factors such as the implementation of stricter food safety regulations, a rise in the frequency of foodborne illnesses, advancements in diagnostic methods, educational awareness programs, and improvements in healthcare infrastructure.

The listeria monocytogenes infections treatment market size is expected to see strongly grown in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. Anticipated growth in managing Listeria monocytogenes infections in the forecast period is linked to several factors, including the globalization of food supply chains, ongoing research and development efforts in antimicrobial treatments, shifts in dietary patterns, increased international collaboration in healthcare, and a heightened focus on public health preparedness.

The listeria monocytogenes infection treatment market is poised for growth owing to the increasing prevalence of foodborne diseases. These illnesses, stemming from consuming contaminated food or beverages, encompass concerns related to listeria monocytogenes infections. The treatment for such infections mitigates risks and curbs the severity of the disease. Notably, in December 2022, the European Food Safety Authority reported a 29.8% surge in foodborne incidents, recording approximately 4,005 cases in 2021 compared to the previous year. This escalation underscores the pivotal role of the rising foodborne disease incidence in propelling the listeria monocytogenes infection treatment market.

Government-led initiatives in healthcare research and development are set to bolster the listeria monocytogenes infection treatment market. These initiatives encompass targeted actions, policies, or funding programs by government entities to address healthcare concerns. Notably, the UK government's commitment of £260 million (US $270.65 million) in 2022 towards healthcare research and manufacturing stands as a testament to this drive. This substantial funding aims to support NHS-led health research, privacy-preserving platforms for diagnostics and treatment, and the expansion of life sciences manufacturing. Such governmental backing significantly impacts the growth trajectory of the listeria monocytogenes infection treatment market.

The listeria monocytogenes infection treatment market is set to expand further owing to the escalating healthcare expenditure. This expenditure represents the cumulative spending on healthcare-related goods and services within an economy or healthcare system. The increased allocation of funds plays a pivotal role in fostering the development and accessibility of listeria monocytogenes infection treatment. For instance, in November 2022, healthcare expenditure in Canada surged to $331 billion, marking an increase of 0.8% from the previous year's 7.6%. This upward trend in healthcare expenditure significantly fuels the growth dynamics of the listeria monocytogenes infection treatment market.

Key companies in the listeria monocytogenes infection treatment market are prioritizing innovation, exemplified by products like Microgen Listeria-ID. This microbiological test, launched by Gold Standard Diagnostics in April 2023, enables the detection and confirmation of Listeria bacteria in food and environmental samples. Microgen Listeria-ID offers a comprehensive identification process, swiftly detecting and distinguishing Listeria spp species without additional materials. Renowned for its rapid and reliable identification, this test significantly expedites quality control measures and monitoring in food processing facilities, contributing to market revenue and efficiency.

In September 2022, Team Arnav Foundation, a US-based nonprofit group focused on finding treatment for juvenile sarcoma cancer, partnered with OS Therapies LLC. With this partnership, Team Arnav Foundation supports the phase IIb trial of OST-HER2 (Listeria monocytogenes) in recurrent, resected osteosarcoma. Additionally, Team Arnav's primary mission is to fund research that would lead to better treatments, higher cure rates, and reduced side effects for patients with malignant bone and soft tissue cancers. OS Therapies LLC is a US-based clinical-stage therapeutic company that develops immunotherapies based on live attenuated listeria monocytogenes (Lm) for solid tumors such as osteosarcoma.

Major companies operating in the listeria monocytogenes infections treatment market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Biogen Inc., Vertex Pharmaceuticals Incorporated, Fresenius Kabi AG, Aurobindo Pharma Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., ZydusCadila Health Care Ltd., Emergent Bio Solutions Inc., Wockhardt Ltd., Hainan Poly Pharm Co. Ltd., Novel Laboratories Inc., Bionpharma Inc., LimmaTech Biologics AG

North America was the largest region in the listeria monocytogenes infections treatment market in 2023. The regions covered in the listeria monocytogenes infections treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the listeria monocytogenes infections treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The listeria monocytogenes infections treatment market consists of revenues earned by entities by provide services such as diagnosis, antibiotic therapy, medical consultations, and nutritional support. The market value includes the value of related goods sold by the service provider or included within the service offering. The listeria monocytogenes infections treatment market also includes sales of penicillin G, meropenem, and trimethoprim-sulfamethoxazole (TMP-SMX). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Listeria Monocytogenes Infections Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on listeria monocytogenes infections treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for listeria monocytogenes infections treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The listeria monocytogenes infections treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Class: Ampicillin; Gentamicin; Vancomycin; Other Drug Classes
  • 2) By Type Of Infection: Gastroenteritis; Endocarditis; Meningitis; Bacteremia; Brain Abscess
  • 3) By Mode Of Administration: Oral; Injectable; Other Mode Of Administrations
  • 4) By End Users: Hospitals; Home Care; Specialty Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Listeria Monocytogenes Infections Treatment Market Characteristics

3. Listeria Monocytogenes Infections Treatment Market Trends And Strategies

4. Listeria Monocytogenes Infections Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Listeria Monocytogenes Infections Treatment Market Size and Growth

  • 5.1. Global Listeria Monocytogenes Infections Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Listeria Monocytogenes Infections Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Listeria Monocytogenes Infections Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Listeria Monocytogenes Infections Treatment Market Segmentation

  • 6.1. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ampicillin
  • Gentamicin
  • Vancomycin
  • Other Drug Classes
  • 6.2. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gastroenteritis
  • Endocarditis
  • Meningitis
  • Bacteremia
  • Brain Abscess
  • 6.3. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • Other Mode Of Administrations
  • 6.4. Global Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Home Care
  • Specialty Clinics
  • Other End Users

7. Listeria Monocytogenes Infections Treatment Market Regional And Country Analysis

  • 7.1. Global Listeria Monocytogenes Infections Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Listeria Monocytogenes Infections Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Listeria Monocytogenes Infections Treatment Market

  • 8.1. Asia-Pacific Listeria Monocytogenes Infections Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Listeria Monocytogenes Infections Treatment Market

  • 9.1. China Listeria Monocytogenes Infections Treatment Market Overview
  • 9.2. China Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Listeria Monocytogenes Infections Treatment Market

  • 10.1. India Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Listeria Monocytogenes Infections Treatment Market

  • 11.1. Japan Listeria Monocytogenes Infections Treatment Market Overview
  • 11.2. Japan Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Listeria Monocytogenes Infections Treatment Market

  • 12.1. Australia Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Listeria Monocytogenes Infections Treatment Market

  • 13.1. Indonesia Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Listeria Monocytogenes Infections Treatment Market

  • 14.1. South Korea Listeria Monocytogenes Infections Treatment Market Overview
  • 14.2. South Korea Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Listeria Monocytogenes Infections Treatment Market

  • 15.1. Western Europe Listeria Monocytogenes Infections Treatment Market Overview
  • 15.2. Western Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Listeria Monocytogenes Infections Treatment Market

  • 16.1. UK Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Listeria Monocytogenes Infections Treatment Market

  • 17.1. Germany Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Listeria Monocytogenes Infections Treatment Market

  • 18.5. France Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Listeria Monocytogenes Infections Treatment Market

  • 19.1. Italy Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Listeria Monocytogenes Infections Treatment Market

  • 20.1. Spain Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Listeria Monocytogenes Infections Treatment Market

  • 21.1. Eastern Europe Listeria Monocytogenes Infections Treatment Market Overview
  • 21.2. Eastern Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Listeria Monocytogenes Infections Treatment Market

  • 22.1. Russia Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Listeria Monocytogenes Infections Treatment Market

  • 23.1. North America Listeria Monocytogenes Infections Treatment Market Overview
  • 23.2. North America Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Listeria Monocytogenes Infections Treatment Market

  • 24.1. USA Listeria Monocytogenes Infections Treatment Market Overview
  • 24.2. USA Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Listeria Monocytogenes Infections Treatment Market

  • 25.1. Canada Listeria Monocytogenes Infections Treatment Market Overview
  • 25.2. Canada Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Listeria Monocytogenes Infections Treatment Market

  • 26.1. South America Listeria Monocytogenes Infections Treatment Market Overview
  • 26.2. South America Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Listeria Monocytogenes Infections Treatment Market

  • 27.1. Brazil Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Listeria Monocytogenes Infections Treatment Market

  • 28.1. Middle East Listeria Monocytogenes Infections Treatment Market Overview
  • 28.2. Middle East Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Listeria Monocytogenes Infections Treatment Market

  • 29.1. Africa Listeria Monocytogenes Infections Treatment Market Overview
  • 29.2. Africa Listeria Monocytogenes Infections Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Listeria Monocytogenes Infections Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Listeria Monocytogenes Infections Treatment Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Listeria Monocytogenes Infections Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Listeria Monocytogenes Infections Treatment Market Competitive Landscape
  • 30.2. Listeria Monocytogenes Infections Treatment Market Company Profiles
    • 30.2.1. Emergent Bio Solutions Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. LimmaTech Biologics AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GlaxoSmithKline plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. ZydusCadila Health Care Ltd
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Listeria Monocytogenes Infections Treatment Market Competitive Benchmarking

32. Global Listeria Monocytogenes Infections Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Listeria Monocytogenes Infections Treatment Market

34. Listeria Monocytogenes Infections Treatment Market Future Outlook and Potential Analysis

  • 34.1 Listeria Monocytogenes Infections Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Listeria Monocytogenes Infections Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Listeria Monocytogenes Infections Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer